Multimodality treatment strategies have changed prognosis of peritoneal metastases

doi:10.4251/wjgo.v8.i1.67

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8129)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-2) series.

Item

Count

PDF

507

WORD

378

HTML

4559

Figures (1-10)

195

Tables (1-2)

185

Sum=5824

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

974

Download

1331

Sum=2305

Jan 15, 2016 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jan 15, 2016; 8(1): 67-82
Published online Jan 15, 2016. doi: 10.4251/wjgo.v8.i1.67

Full Size Figure Download Figure

Figure 7 Kaplan-Meier survival curve of colorectal peritoneal carcinomatosis treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, stratified according to the size of residual tumors (A) and the number of regions with residual tumors (B)[35] (with permission). Kaplan-Meier survival curve of CRS-HIPEC treatment, for Colorectal PM, stratified by the number of regions affected (A) and the number of regions with residual tumors (B)[35]: http://click.info.copyright.com/?qs=2b7046b10dd0c5471bbbb8bac0096e00e895f442c0326423c4ec2ccdd7b4701b99fd4bd5b32f0283. CRS-HIPEC: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy; PM: Peritoneal metastases.

Citation: Lungoci C, Mironiuc AI, Muntean V, Oniu T, Leebmann H, Mayr M, Piso P. Multimodality treatment strategies have changed prognosis of peritoneal metastases. World J Gastrointest Oncol 2016; 8(1): 67-82
URL: https://www.wjgnet.com/1948-5204/full/v8/i1/67.htm
DOI: https://dx.doi.org/10.4251/wjgo.v8.i1.67